Cincinnati Children's is conducting a research study, sometimes known as a clinical trial or clinical study, to understand the benefits and side effects of medicines often used to treat attention deficit hyperactivity disorder (ADHD) in children with autism. We want to determine the relative effectiveness of the most commonly prescribed FDA-approved medications for the treatment of ADHD in children and adolescents with autism.
Children and teens 4 to 17 years old and who:
The study involves up to 9 visits to Cincinnati Children’s Hospital over 19 weeks. Most can be done over the phone or video calls. Study visits include:
You will be given a consent form that thoroughly explains all the details of the study. A member of the study staff will review the consent form with you and will be sure that all your questions are answered.
Your child may or may not receive any benefits from taking part in the study. The results of this study may provide information that could help improve available treatment in the future.
We will discuss all possible risks or discomforts with those interested in learning more about the study.
Participants will receive up to $100 for their time and effort.
Lead Study Principal Investigator: Dan Coury, MD
Site Principal Investigator: Julia Anixt, MD
Division of Developmental & Behavioral Pediatrics
Cincinnati Children’s Hospital Medical Center